Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
i-bendroflumethiazide
ipca pharma (nz) pty limited - bendroflumethiazide 5mg; ; - tablet - 5 mg - active: bendroflumethiazide 5mg excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
bendroflumethiazide
ipca pharma (nz) pty limited - bendroflumethiazide 2.5mg; ; - tablet - 2.5 mg - active: bendroflumethiazide 2.5mg excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
bendroflumethiazide
ipca pharma (nz) pty limited - bendroflumethiazide 5mg; ; - tablet - 5 mg - active: bendroflumethiazide 5mg excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
Malte -
anglais -
Medicines Authority
bendroflumethiazide 2.5mg tablets
p & d pharmaceuticals limited - bendroflumethiazide 2.5 mg - tablet
Malte -
anglais -
Medicines Authority
bendroflumethiazide tablets bp 5mg
actavis uk limited - bendroflumethiazide 5 mg - tablet
Malte -
anglais -
Medicines Authority
bendroflumethiazide tablets 2.5mg
cherubino limited - bendroflumethiazide 2.5 mg - tablet
Malte -
anglais -
Medicines Authority
bendroflumethiazide tablets 2.5mg
bristol laboratories limited - bendroflumethiazide 2.5 mg - tablet
Royaume-Uni -
anglais -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bendroflumethiazide 1.25mg/5ml oral suspension
special order - bendroflumethiazide - oral suspension - 250microgram/1ml
Royaume-Uni -
anglais -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bendroflumethiazide 1mg/5ml oral suspension
special order - bendroflumethiazide - oral suspension - 200microgram/1ml
Royaume-Uni -
anglais -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bendroflumethiazide 2.5mg/5ml oral suspension
drug tariff special order - bendroflumethiazide - oral suspension - 500microgram/1ml